CUSIP: 576314108
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,736,982
-
Share change
-
-3,549,986
-
Total reported value
-
$11,782,000
-
Put/Call ratio
-
0%
-
Price per share
-
$0.63
-
Number of holders
-
30
-
Value change
-
-$2,392,840
-
Number of buys
-
10
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP 576314108?
CUSIP 576314108 identifies MSTX - MAST THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2014
-
Previous quarter:
Q1 2014
Recent filing periods for CUSIP 576314108:
Institutional Holders of MAST THERAPEUTICS INC - COM (MSTX) as of Q2 2014
As of 30 Jun 2014,
MAST THERAPEUTICS INC - COM (MSTX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,736,982 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, VANGUARD GROUP INC, DEUTSCHE BANK AG\, GEODE CAPITAL MANAGEMENT, LLC, MPM ASSET MANAGEMENT LLC, GRT CAPITAL PARTNERS LLC, Iguana Healthcare Management, LLC, DIMENSIONAL FUND ADVISORS LP, Bank of New York Mellon Corp, and Ancora Advisors, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.